|
|
|
|
|
|
Robert Koch and
Tuberculosis
|
|
|
Koch's Famous
Lecture |
|
Robert Koch, Nobel Laureate, 1905. |
|
|
|
|
The medal given to Nobel Laureates in Physiology or Medicine.
Registered trademark of the Nobel Foundation |
|
|
Robert Koch, a German physician and scientist,
presented his discovery of Mycobacterium
tuberculosis, the bacterium that causes
tuberculosis (TB), on the evening of March 24, 1882.
He began by reminding the audience of terrifying
statistics: "If the importance of a disease for
mankind is measured by the number of fatalities it
causes, then tuberculosis must be considered much
more important than those most feared infectious
diseases, plague, cholera and the like. One in seven
of all human beings dies from tuberculosis. If one
only considers the productive middle-age groups,
tuberculosis carries away one-third, and often
more."
Koch's lecture, considered by many to be the most
important in medical history, was so innovative,
inspirational and thorough that it set the stage for
the scientific procedures of the twentieth century.
He described how he had invented a new staining
method and demonstrated it for the audience. Koch
brought his entire laboratory to the lecture room:
microscopes, test tubes with cultures, glass slides
with stained bacteria, dyes, reagents, glass jars
with tissue samples, etc. He wanted the audience to
check his findings for themselves. Koch showed tissue
dissections from guinea pigs which were infected with
tuberculous material from the lungs of infected apes,
from the brains and lungs of humans who had died from
blood-borne tuberculosis, from the cheesy masses in
lungs of chronically infected patients and from the
abdominal cavities of cattle infected with TB. In all
cases, the disease which had developed in the
experimentally infected guinea pigs was the same, and
the cultures of bacteria taken from the infected
guinea pigs were identical. One important scientist
in the audience was Paul Ehrlich (Nobel Laureate in
Physiology or Medicine in 1908) who later confessed,
"I hold that evening to be the most important
experience of my scientific life." When Koch ended
his lecture there was complete silence. No questions,
no congratulations, no applause. The audience was
stunned. Slowly people got up and started looking
into the microscopes to see the TB bacteria with
their own eyes.
News of Koch's discovery spread rapidly. The
results were published in a German medical journal on
April 10, in England after a rapid translation in
The Times on April 22, and in the US in The
New York Times on May 3, 1882. Robert Koch was
now a famous scientist and became known as "The
Father of Bacteriology." He was presented with the
Nobel Prize in Physiology or Medicine in 1905 "for
his investigations and discoveries in relation to
tuberculosis."
|
|
|
The Infection and
Disease |
|
|
Today, more than a century after Koch discovered
Mycobacterium tuberculosis, there are still
many infected individuals and around two million
deaths annually resulting from the disease.
Tuberculosis is a global disease which is not only
specific to humans. There are variants of the TB
bacterium that infect cattle (milk was known to
transmit the disease from cattle to humans before
heat treatment - pasteurization - efficiently removed
the risk), birds, fish, turtles and frogs.
In humans, symptoms of active TB often include
coughing, fever, nightly sweats and wasting of the
body. TB usually affects the lungs, but it can also
affect the brain, the kidneys or the skeleton. The
symptoms of TB of the lungs include persistent
coughing, chest pain and coughing up blood. Symptoms
involving other areas of the body vary, depending on
the affected organ.
Tuberculosis is spread from person to person through the air, in tiny microscopic droplets. When a person with TB in the lungs coughs or sneezes, the bacteria can be inhaled by persons nearby, often family members or co-workers.
Usually, persons infected with tuberculosis harbor the bacteria without developing symptoms. This condition is called "latent TB infection." In this state, the bacteria are inactive, kept in check by the body's immune defense system. The person does not feel sick. However, the disease may become active in the future. It is estimated that one-third of all living beings are latently infected.
People with HIV/AIDS are particularly vulnerable to reactivation of latent TB infection to active disease. This is because the HIV-infected individual has a weakened immune system. About one-third of the more than 40 million HIV/AIDS patients are co-infected with TB bacteria. TB is actually the cause of death in many HIV-infected individuals. In fact, anything which weakens the body's immune defense system can cause latent TB infection to become active disease.
|
|
|
Treatment of
TB |
|
Paul Ehrlich, Nobel Laureate, 1908.
|
|
Gerhard Domagk, Nobel Laureate, 1939.
|
|
Selman Waksman, Nobel
Laureate, 1952. |
|
|
Even after the identification of the TB bacterium
and the establishment of tuberculosis as an
infectious disease, the standard medical therapy for
decades to come was based on rest, the sanatorium,
and a good climate with lots of fresh cold air. Why?
Because it took a long time before antibacterial
drugs were developed.
After Koch's discovery, many attempts were made
over the years to find a compound that could stop the
growth of TB bacteria. In 1910, a German scientist
named Paul Ehrlich discovered a chemical that could
kill the microorganism that causes another disease,
syphilis, and effectively treat that disease. This
initiated the search for other chemical substances
which could destroy disease-causing
microorganisms.
In 1935, another German scientist named Gerhard
Domagk published a report on the use of "Prontosil,"
an organic compound containing sulfur
(sulfanilamide), for treatment of bacterial
infections. Domagk was awarded The Nobel Prize in
Physiology or Medicine for his discovery in 1939.
Prontosil, and derivatives of it, had some effect on
TB bacteria in laboratory studies, but only in
concentrations that would be poisonous to humans.
Other ideas were pursued independently. Scientists
observed that pathogenic (disease-causing) bacteria
do not survive for long in enriched soil. It was
found that fungi living in the soil were able to
suppress their growth. In 1943, an American named
Selman Waksman, together with his co-workers,
discovered that a fungus called Streptomyces
griseus produced an antibiotic substance which
they named "streptomycin." After successful animal
tests, the first tuberculosis patient was treated in
1944, and she was cured of her life-threatening
disease! Further trials confirmed that streptomycin
was indeed effective in the treatment of
tuberculosis. Selman Waksman was awarded the Nobel
Prize in Physiology or Medicine in 1952 for his
discovery of streptomycin.
Unfortunately, early in the studies, it became
evident that the TB bacteria were becoming resistant
to streptomycin. This severely reduced the usefulness
of the drug for treating tuberculosis.
In 1943, another drug called para-aminosalicylic
acid (PAS) was developed. When this drug was used
together with streptomycin it prevented the TB
bacteria from becoming resistant. However, the
patient had to use the drugs for periods of months in
order to be cured.
Another drug called "isoniazid," a derivative of a
compound researched earlier by Domagk, was developed
in 1952. It also found its place in TB therapy.
Thus, in the decade between 1944 and 1954, largely
due to the work of Nobel Laureates, three drugs -
streptomycin, PAS and isoniazid – became
available. When taken in combination, and for a
sufficient length of time, the prognosis for a
patient with TB disease changed from dismal to the
expectation of cure.
Today, the cornerstone for any treatment of
tuberculosis is still multidrug therapy. At least two
drugs are given at the same time to prevent the
emergence of drug resistance. Sometimes patients are
treated with up to four different antibacterial
drugs, and for periods of a minumum of 6 to 24
months.
|
|
|
Tuberculosis in Human
History |
|
|
Tuberculosis, once called "consumption" and "white
plague," is an ancient disease that may have always
been with us. Evidence of tubercular decay found in
the skulls and spines of Egyptian mummies, tell us
that TB has been plaguing humans for at least 4,000
years. Hippocrates, the ancient Greek physician,
noted that "phthisis" (consumption) was the most
widespread and fatal disease of his time.
It has been estimated that in the two centuries
from 1700 to 1900, tuberculosis was responsible for
the deaths of approximately one billion (one thousand
million) human beings. The annual death rate from TB
when Koch made his discovery, was seven million
people. Although the disease has not been eradicated,
there is no doubt that Robert Koch's discovery of the
tubercle bacillus, subsequent inventions for curing
infected and sick individuals as well as the
application of measures to prevent the spread of TB,
has had a profound impact on human history and has
saved many lives.
First published 9 December 2003
|
|
|